quinazolines has been researched along with Coronary Disease in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (76.32) | 18.7374 |
| 1990's | 6 (15.79) | 18.2507 |
| 2000's | 2 (5.26) | 29.6817 |
| 2010's | 1 (2.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabró, V; Fischerman, L; Fraga, CG; Galleano, M; Piotrkowski, B; Vazquez Prieto, MA | 1 |
| GRIFFIN, R; STEIGMANN, F | 1 |
| COOKE, AR | 1 |
| Foss, PO; Helgeland, A; Hjermann, I; Holme, I; Leren, P; Lund-Larsen, PG | 1 |
| Bando, S; Kakutani, A; Minezono, K; Mori, H; Noda, T; Shinomiya, H | 1 |
| Lowenstein, J | 1 |
| Benfey, BG; Elfellah, MS; Ogilvie, RI; Varma, DR | 1 |
| Coxon, R; Sharpe, DN | 1 |
| Goebel, R; Klein, W | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Młyński, J | 1 |
| Silke, B; Taylor, SH | 1 |
| Lund-Johansen, P; Ohm, OJ; von der Lippe, G | 1 |
| Hendry, WG; Silke, B; Taylor, SH | 1 |
| Kazmaier, S; Sonntag, H; Stephan, H | 1 |
| Autschbach, R; Becker, B; Lange, H; Mohr, FW; Sonntag, H; Stephan, H | 1 |
| Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H | 1 |
| Awan, NA; Hermanovich, J; Mason, DT; Skinner, P; Whitcomb, C | 1 |
| Bartolo, M; Di Lorenzo, M; Pittorino, L; Ricci, G | 1 |
| Awan, NA; Mason, DT; Miller, RR | 1 |
| Jackson, PG; Jennings, K; Jewitt, DE; Monaghan, M | 1 |
| Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT | 1 |
| Gentili, S; Pede, S; Schiaroli, M; Timio, M | 1 |
| Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A | 1 |
| Conely, JM; Hillis, WS; Hutton, I; Langhan, CE; Lawrie, TD | 1 |
| Abe, Y; Abiko, Y; Ichihara, K | 1 |
| Haneda, T; Obata, H; Tanaka, H | 1 |
| Esato, K; Katoh, T; Miyamoto, M; Mori, F | 1 |
| Abiko, Y; Ichihara, K; Yoshida, R | 1 |
| Ozawa, T; Sugiyama, S | 1 |
| Kawai, C; Murohara, Y; Takatsu, Y; Yui, Y | 1 |
| Geshi, E; Hiroshige, J; Katagiri, T; Konno, N; Mochizuki, M; Umetsu, K | 1 |
| Kane, KA; Morcillo-Sanchez, EJ; Parratt, JR; Rodger, IW; Shahid, M | 1 |
| Gordon, M; Nayler, WG; Stephens, DJ; Sturrock, WJ | 1 |
| Bayliss, J; Canepa-Anson, R; Norell, MS; Poole-Wilson, P; Reid, C; Sutton, G | 1 |
| Benedict, CR; Cartwright, J; Mathew, B; Rex, KA; Sordahl, LA | 1 |
6 trial(s) available for quinazolines and Coronary Disease
| Article | Year |
|---|---|
Effect of propranolol and prazosin on blood lipids. The Oslo Study.
Topics: Cerebrovascular Disorders; Cholesterol; Coronary Disease; Drug Antagonism; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Propranolol; Quinazolines; Risk; Triglycerides | 1980 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Pulmonary Wedge Pressure; Quinazolines; Random Allocation; Renin; Stroke Volume; Vascular Resistance | 1982 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
[Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
Topics: Adult; Aged; Anesthesia; Blood Pressure; Coronary Disease; Enoximone; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Quinazolines; Stroke Volume; Vascular Resistance | 1995 |
Effects of R80122, a new phosphodiesterase inhibitor, on liver and global haemodynamics in patients undergoing coronary artery bypass surgery.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Hemodynamics; Humans; Imidazoles; Intraoperative Care; Liver; Male; Middle Aged; Phosphodiesterase Inhibitors; Quinazolines; Statistics, Nonparametric | 1994 |
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
Topics: Aged; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Proline; Quinazolines; Renin-Angiotensin System; Time Factors | 1985 |
32 other study(ies) available for quinazolines and Coronary Disease
| Article | Year |
|---|---|
Modifications in nitric oxide and superoxide anion metabolism induced by fructose overload in rat heart are prevented by (-)-epicatechin.
Topics: Animals; Coronary Disease; Fructose; Heart; Humans; Male; Myocardium; Nitric Oxide; Oxidative Stress; Quinazolines; Rats; Rats, Sprague-Dawley; Superoxides | 2016 |
EVALUATION OF QUINETHAZONE, A NEW DIURETIC.
Topics: Ascites; Coronary Disease; Diuretics; Edema; Hypertension; Liver Cirrhosis; Quinazolines; Rheumatic Heart Disease; Sulfonamides | 1963 |
A CLINICAL TRIAL OF A NEW QUINAZOLINONE DIURETIC.
Topics: Coronary Disease; Diuretics; Edema; Humans; Liver Cirrhosis; Nephrotic Syndrome; Organomercury Compounds; Quinazolines; Quinazolinones; Sulfonamides | 1964 |
Top 10 health stories of 2004.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antidepressive Agents; Antineoplastic Agents; Biomedical Research; Cholesterol, LDL; Cloning, Organism; Coronary Disease; Delivery of Health Care; Dementia; Gefitinib; Humans; Influenza Vaccines; Insurance, Health; Lactones; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Quinazolines; Registries; Sulfones; Walking | 2004 |
[Effects of E-643 on the regional myocardial function and hemodynamics in experimental acute coronary artery occlusion].
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Disease; Dogs; Hemodynamics; Myocardial Contraction; Quinazolines | 1983 |
Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983.
Topics: Adrenergic beta-Antagonists; Benzothiadiazines; Chlorthalidone; Cholesterol; Cholesterol, HDL; Coronary Disease; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Lipids; Lipoproteins, HDL; Prazosin; Quinazolines; Risk; Sodium Chloride Symporter Inhibitors; Triglycerides | 1984 |
Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Dogs; Drug Therapy, Combination; Heart Rate; Heart Ventricles; Male; Perfusion; Prazosin; Propranolol; Quinazolines; Swine; Tachycardia; Ventricular Fibrillation | 1984 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinephrine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Norepinephrine; Physical Exertion; Prazosin; Quinazolines; Vascular Resistance | 1980 |
[Effect of prazosin on changes in blood lipids].
Topics: Coronary Disease; Humans; Hyperlipoproteinemia Type IV; Hypertension; Lipoproteins, HDL; Lipoproteins, VLDL; Prazosin; Quinazolines; Triglycerides | 1982 |
Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.
Topics: Aged; Blood Pressure; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Posture; Prazosin; Pulmonary Artery; Quinazolines | 1981 |
Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
Topics: Adult; Aged; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.
Topics: Coronary Disease; Hemodynamics; Humans; Physical Exertion; Prazosin; Quinazolines | 1981 |
Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Carbazoles; Cardiac Catheterization; Carvedilol; Coronary Disease; Coronary Stenosis; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Hemodynamics; Male; Metoprolol; Norepinephrine; Propanolamines; Propranolol; Quinazolines; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stroke Volume; Survival Rate; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Ventricular Remodeling | 2002 |
The role of prazosin in the management of hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Anesthesia, General; Child; Coronary Disease; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Quinazolines | 1977 |
Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Drug Evaluation; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Piperazines; Plethysmography; Pulmonary Circulation; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1979 |
[Flow measurement characteristics in heart patients after the acute and protracted administration of 2 vasoactive drugs: prazosin hydrochloride and isosorbide dinitrate].
Topics: Blood Circulation; Coronary Disease; Humans; Hyperemia; Isosorbide Dinitrate; Prazosin; Quinazolines; Time Factors | 1979 |
Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.
Topics: Adult; Aged; Blood Circulation; Coronary Disease; Female; Ferricyanides; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1978 |
Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease.
Topics: Aged; Cardiac Output; Coronary Disease; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperidines; Quinazolines; Vascular Resistance | 1978 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine; Nitroprusside; Prazosin; Quinazolines; Sodium; Tachycardia | 1978 |
[Prazosin in refractory congestive heart failure].
Topics: Adult; Aged; Coronary Disease; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1978 |
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease; Coronary Disease; Drug Evaluation; Dyspnea; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1977 |
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease.
Topics: Coronary Disease; Hemodynamics; Humans; Male; Myocardial Contraction; Myocardial Infarction; Phosphodiesterase Inhibitors; Piperidines; Quinazolines | 1977 |
Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Carbohydrate Metabolism; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Male; Myocardium; Phosphocreatine; Phosphofructokinase-1; Quinazolines; Quinazolinones | 1991 |
Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Atenolol; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Disease; Lactates; Lactic Acid; Male; Myocardium; Phosphocreatine; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Remission Induction | 1991 |
Effect of combined dopamine and bunazosin on the ischemic heart after occlusion of the coronary artery.
Topics: Adrenergic alpha-Antagonists; Animals; Arterial Occlusive Diseases; Cardiac Output, Low; Coronary Circulation; Coronary Disease; Dogs; Dopamine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemodynamics; Infusions, Intravenous; Myocardium; Oxygen Consumption; Quinazolines | 1990 |
Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Topics: Adenine Nucleotides; Adrenergic alpha-Antagonists; Animals; Carbohydrate Metabolism; Coronary Disease; Dogs; Electrocardiography; Energy Metabolism; Female; Heart; Hemodynamics; Hexosephosphates; In Vitro Techniques; Lactates; Male; Myocardium; Phosphocreatine; Pyruvates; Quinazolines | 1990 |
Biochemical basis for reperfusion arrhythmias.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Coronary Circulation; Coronary Disease; Dogs; Female; Ion Channels; Male; Mitochondria, Heart; Myocardium; Phospholipases; Quinazolines | 1987 |
[The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cilostazol; Coronary Disease; Coronary Thrombosis; Cyclic AMP; Dipyridamole; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Tetrazoles | 1989 |
Protection of acute ischemic myocardial injury by pharmacological intervention.
Topics: Adenosine Triphosphatases; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium-Transporting ATPases; Coenzymes; Coronary Disease; Diltiazem; Dogs; Myocardium; Niacinamide; Nicorandil; Quinazolines; Sarcoplasmic Reticulum; Ubiquinone; Vasodilator Agents | 1989 |
The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat.
Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Heart; Male; Myocardium; Quinazolines; Rats; Rats, Inbred Strains | 1985 |
The protective effect of prazosin on the ischaemic and reperfused myocardium.
Topics: Adenosine Triphosphate; Animals; Calcium; Coronary Disease; Diltiazem; Male; Myocardial Contraction; Myocardium; Phosphocreatine; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha | 1985 |
Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation.
Topics: Adenosine Diphosphate; Animals; Arteries; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Electric Stimulation; Female; Male; Microscopy, Electron, Scanning; Platelet Aggregation; Quinazolines; Serotonin | 1986 |